SCHEMBL8006327

SCHEMBL8006327

Cc1nc(-c2nc(-c3ccc(C#N)cc3)c(Sc3ccc(Cl)cc3)n2C)cs1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.52
FAAH O00519 1/20 0.47
MAOA P21397 2/20 0.43
MAOB P27338 2/20 0.43
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
MAPT P10636 3/20 0.37
ALDH1A1 P00352 1/20 0.36
L3MBTL1 Q9Y468 3/20 0.36
NPSR1 Q6W5P4 2/20 0.36
TDP1 Q9NUW8 3/20 0.35
LMNA P02545 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
RECQL P46063 1/20 0.34
PRKDC P78527 1/20 0.34
CFTR P13569 1/20 0.33
MYC P01106 1/20 0.33
WDR5 P61964 1/20 0.33
EGFR P00533 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12106886 0.84 FAAH (0.48) GAAFAAHMAOAMAOBMAPT
SCHEMBL1304298 0.83 FAAH (0.67) GAAFAAHMAOAMAOBALDH1A1
SCHEMBL1302719 0.83 FAAH (0.50) GAAFAAHMAOAMAOBMAPT
SCHEMBL8006548 0.82 MAOA (0.46) GAAFAAHMAOAMAOBMAPT
SCHEMBL8005254 0.82 FAAH (0.55) FAAHMAOAMAOBNPC1RAB9A
SCHEMBL1303162 0.81 FAAH (0.45) GAAFAAHMAOAMAOBNPC1
SCHEMBL12106878 0.80 FAAH (0.44) GAAFAAHMAOAMAOBALDH1A1
SCHEMBL7993050 0.80 FAAH (0.44) GAAFAAHNPC1RAB9AMAPT
SCHEMBL1303791 0.79 MAOA (0.50) FAAHMAOAMAOBMAPTALDH1A1
SCHEMBL1302358 0.79 FAAH (0.43) GAAFAAHMAOAMAOBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
WO-2009152025-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK & CO., INC. (US) 2009-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, HNMT GAA 1269/4885FAAH 1/4885MAOA 61/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.